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Abstract 
Background: Re-sleeve gastrectomy (re-SG) is a possible option to increase weight loss 
after biliopancreatic diversion with duodenal switch (BPD-DS). We report the feasibility, 
efficacy and safety of re-SG in patients presenting with long-term weight regain after 
BPD-DS. 
Methods: From October 2010 to December 2013, a total of 17 patients (12 female, 5 
male) with a mean age of 42.1±19.4 years underwent re-SG, mainly because of weight 
regain after BPD-DS. Re-SG was performed laparoscopically over a 32 French stomach 
tube. 
Results: At the time of BPD-DS, the mean weight and BMI of all patients was 
130.1±17.9kg and 46.1±6.5kg/m2, respectively. The mean time interval between BPD-
DS and re-SG was 63.1±20.3 months. At the time of re-SG, the mean weight and BMI 
was 115.4±14.2kg and 39.8±5.3kg/m2, and the %EWL after BPD-DS was 22.9±17.4%. 
Three conversions (17.6%) to open surgery were required. No mortality occurred. One 
patient (5.9%) developed a leak within the first week after re-SG that was treated 
conservatively with an endoluminal stent. The mean follow-up was 37.2±7.1 months 
after re-SG. One- and three years follow-up showed a mean weight, BMI, and 
cumulative %EWL of 96.0±17.1kg, 33.8±7.3kg/m2, and 53.1±18.3% (17/17 patients; 
100%), and 100.3±21.1kg, 35.1±8.3kg/m2, and 47.2±19.7% (13/17 patients; 76%) after 
re-SG, respectively. 
Conclusions: This study shows that re-SG in patients with weight regain after BPD-DS is 
a feasible, effective and safe option as a revisional bariatric procedure. However, 
patients have to be carefully considered for revisional surgery since re-SG is associated 
with the potential risk for surgical complications. 
Key words: bariatric surgery, revisional surgery, weight regain, sleeve gastrectomy, 
biliopancreatic diversion with duodenal switch 
 
  
Introduction 
Biliopancreatic diversion with duodenal switch (BPD-DS) is a very effective bariatric 
procedure for sustainable long-term weight loss in the treatment of morbid obesity [1-3]. 
BPD-DS is known for the highest amount of weight loss among all bariatric procedures 
[3]. Nevertheless, this operation was less commonly performed within the last twenty 
years because of its side effects including malabsorption and surgically induced 
malnutrition [1, 4]. BPD-DS relies on gastric restriction by sleeve gastrectomy (SG) 
combined with the malabsorptive biliopancreatic diversion [2, 3]. Despite its excellent 
perspective in terms of weight loss, long-term weight regain can also occur after BPD-
DS, especially in super-obese patients [5, 6]. In these patients, a multidisciplinary 
approach is necessary to determine the contributive factors for weight regain [7]. The 
reevaluation includes a psychologist and a nutritionist that has to rule out any presence 
of a new mental disorder or dietary behavior [8]. Further examinations should also 
exclude the appearance of gastroesophageal reflux (GERD) or a possible dilation of the 
SG [9-11]. The treatment than will depend on the different findings of the evaluations.  
In BPD-DS, there are only limited options for revisional surgery to correct long-term 
weight regain such as changing the gastric volume or the lengths of the small bowel 
channels [12]. Re-SG has, therefore, to be considered in these patients as recent 
reports demonstrate that SG has the tendency to dilate over time [11, 13-15]. We 
postulated that re-SG could increase further weight loss after BPD-DS when a dilated 
SG was present. The aim of this study was to analyze the feasibility, efficacy and safety 
of re-SG in patients presenting with long-term weight regain after BPD-DS. 
  
Materials and Methods 
Patients: 
Between October 2010 and December 2013, a total of 17 out of 112 patients (15.2%) 
were identified with sustainable weight regain after BPD-DS. The indication for re-SG 
was determined after a multidisciplinary reevaluation of the patient including 
psychological and nutritional counseling, a gastrographin contrast swallow study and a 
gastroscopy.  
Surgical technique: 
The surgical procedure was performed starting with the insertion of a video-guided 
12mm trocar in the left upper quadrant of the abdomen. Four additional trocars were 
placed under the direct view (two 5mm and two 12mm trocars). Re-SG started with a 
complete adhesiolysis of the greater omentum from the abdominal wall and detaching 
the left liver lobe from the gastric sleeve. A 32-French stomach tube was inserted by an 
anesthesiologist to reach the pylorus. The Echelon 60mm linear stapler (Ethicon 
Endosurgery, Cincinnati, OH, USA) with green or blue loads as a routine choice was 
used in all procedures. Staple line buttressing was not used, but hemostatic clips were 
applied whenever required on the gastric staple lines. The resected stomach was 
removed in a plastic bag through a left flank trocar incision, and a leakage test with 
methylene blue was performed. A drain was left in place along the staple line, and a 
leakage test with methylene blue was performed. 
Postoperative management: 
Thromboembolic prophylaxis was given using twice 40mg/d enoxaparin (Clexane) six 
hours after surgery for 4 weeks. Automatic compression devices were used during the 
whole operating time and were left in place for the first 24 to 48 hours. The patients 
received a clear liquid diet for the first 24 hours after the procedure and was discharged 
after five days if no postoperative complications occurred. Dietary restrictions included a 
concept a strict pureed diet for four weeks. Follow-up visits were scheduled at our 
outpatient bariatric clinic at 1, 3, 6, and 12 months after re-SG and every six months 
from that time point forward including a clinical examination and a nutritional blood 
screening test. 
Statistical analysis:  
Data were analysed using Prism 6 (Version 6.0d; GraphPad Software). Results are 
presented as mean values with standard deviation (SD) unless specified otherwise. For 
categorical variables, we calculated the frequencies of the categories of interest. %EWL 
was calculated to the ideal weight set at a BMI of 25kg/m2. 
 
 
 
  
Results 
At the time of BPD-DS, mean weight of all patients was 130.1±17.9kg (range 108-176) 
and BMI 46.1±6.5kg/m2 (range 37.5-53.7) (figure 1 and 2). Obesity-related comorbidities 
affected all patients, including arterial hypertension in 12 (70.6%), dyslipidemia in 7 
(41.2%), type 2 diabetes mellitus (DM) in 6 (35.3%), and obstructive sleep apnea 
syndrome (OSAS) in 5 (29.4%) patients. 
The mean time interval between BPD-DS and re-SG was 63.1±20.3 months. At the time 
of re-SG, mean weight was 115.4±14.2kg (range 96-151), BMI 39.8±5.3kg/m2 (range 
33.2-47.9), and %EWL 22.9±17.4% (range 3.9-41.9) (figure 1-3). Obesity-related 
comorbidities at this time affected 15 of 17 patients (88.2%), including arterial 
hypertension in 10 (58.9%), dyslipidemia in 7 (41.2%), type 2 DM in 5 (29.4.3%), and 
OSAS in 4 (23.5%) patients. 
The mean operative time for re-SG was 107±83 minutes (range 48–240). Three 
conversions (17.6%) to open surgery were required due to severe intraabdominal 
adhesions. No mortality occurred. One patient (5.9%) presented with a leak at the angle 
of His within the first week after re-SG that was treated conservatively with an 
endoluminal stent. The mean hospital stay was 9.3±19.7days (range 5–63).  
The mean follow-up was 37.2±7.1 months (range 31-48) after re-SG. At 1 year of follow-
up (17 patients; complete follow-up), mean weight was 96.0±17.1kg (range 78-135), BMI 
33.8±7.3kg/m2 (range 28.7-43.8), and cumulative %EWL after BPD-DS 53.1±18.3% 
(range 39-132) (figure 1-3). At 3 years of follow-up (13/17 patients; follow-up 76%), 
mean weight was 100.3±21.1kg (range 82-138), BMI 35.1±8.3kg/m2 (range 29.5-45.1), 
and cumulative %EWL after BPD-DS 47.2±19.7% (range 35-97) (figure 1-3). Obesity-
related comorbidities at this time affected 11 of 17 patients (64.7%), including arterial 
hypertension in 7 (41.2%), dyslipidemia in 5 (29.4%), type 2 DM in 5 (29.4%), and 
OSAS in 3 (17.6%) patients. There were not more vitamin or mineral deficiences 
diagnosed 3 years after secondary re-SG compared to 3 years after initial BPD-DS. 
During the follow-up, two patients (11.8%) required surgery for late complications, 
including one trocar-site ventral hernia and one incisional ventral hernia repair. 
Hospitalisation was at 3 and 16 months after re-SG with laparoscopic surgery for hernia 
repair without any complications. 
 
 
  
Discussion  
To our knowledge, this is the first study demonstrating that re-SG in patients with weight 
regain in the long-term after BPD-DS is a feasible, effective and safe surgical option to 
achieve further weight loss after BPD-DS. 
BPD-DS is known to achieve the best results in terms of weight loss among all bariatric 
procedures [1-3]. Nevertheless, weight regain in the long-term can also occur after BPD-
DS, especially in super-obese patients [5-7]. Marceau et al. reported excellent 20 years 
results after BPD-DS with a %EWL of over 70% [3], but Biron et al. mentioned that 
weight regains after BPD-DS is an increasing problem, especially in super-obese 
patients, doubling the failure rate every five years with weight regain [16]. In our series, 
we identified 17 patients with weight regain at a median follow-up of more than 5 years 
after BPD-DS. The mean BMI at time of BPD-DS was 46.1±6.5kg/m2, some of these 
patients were super-obese (BMI >50kg/m2). 
In bariatric surgery, weight regain is a common problem [7, 17, 18]. Even after 
satisfactory weight loss, weight regain can occur if patients go back to bad eating habits 
and sedentary lifestyle [8, 19]. The reasons for weight regain has to be thoroughly 
investigated. Evidence has been growing that psychological issues play an essential 
role [8]. New dietary habits and patient adaptation to the new anatomic circuit are other 
frequent causes of weight regain [7]. Other reasons may be equally important factors 
such as excessive alcohol consumption, craving for sweets, fattening foods in general or 
dilatation of gastric restriction [7, 8]. In BPD-DS, weight regain often results in nutritional 
consequences due to poor intestinal absorption caused by the exclusion of the jejunum 
from the alimentary tract and the short common channel [12, 20, 21]. Weight regain may 
represent a return to full energy utilization, but many essential nutrients are still lost, 
which in BPD-DS may result in severe iron-deficiency anemia, vitamin D deficiency with 
secondary hyperparathyroidism and chronic malnutrition [20, 21]. This situation results 
in an obese individual with various nutritional complications that need to be addressed 
before considering weight loss per se. The follow-up should include medical and 
psychological guidance, including continuing dietary advice and maintenance of a 
physical exercise regimen [22].  
To overcome the problem of weight regain, a multidisciplinary approach is necessary to 
determine the individuals contributive factors to this problem [7]. Psychological disorders 
or changes in eating behavior have been correlated with changes in body weight, 
independent of the reported dietary intake and physical activity [8, 19]. In cases of 
hyperphagia linked to a dilatated gastric sleeve, we offered patients re-SG after BPD-
DS. Gagner et al. reported two cases of re-SG in patients with poor weight loss after 
BPD-DS [14, 15]. When dilation of the SG is present, re-SG appears to be a logical 
option. In SG, Baltasar et al. reported first on two patients who had undergone re-SG for 
dilation of SG, with subsequent increased successive weight loss [23]. Other authors 
reported comparable observation with a substantial of weight regain in up to 23% of SG 
[5, 6, 11, 18]. However, consideration should be given to a possible re-SG since 
additional gastric volume restriction might jeopardize the patient’s psychological balance 
[8]. Also, a radiological examination by gastrographin or barium contrast swallow studies 
does also not seem completely appropriate to evaluate the volume of the SG [11, 24]. 
During our surgical exploration, we did find sufficient space to place the linear staple 
next to the stomach tube. After placement of the stomach tube, excessive redundancy 
was still found toward the antrum and, in some patients, to the fundus.  
During a follow-up of more than 3 years after re-SG, we recorded a cumulative %EWL of 
47.2% after BPD-DS and re-SG compared to %EWL 22.9 after BPD-DS with weight 
regain. An average, all patients lost 11kg after re-SG and showed an improvement of 
remission of comorbidities in some cases. Although an additional restrice procedure was 
added to the BPD-DS, not more vitamin or mineral deficiences were diagnosed 3 years 
after secondary re-SG compared to 3 years after initial BPD-DS. 
In revisional bariatric surgery, the risk for surgical complications is higher and 
complications might be more difficult to treat [1, 11]. In the present series, we recorded 
one (5.9%) early complication with a leak at the angle of His within the first week after 
re-SG. Recent reports have shown that conservative treatment of leakages provides 
better results than reoperation, with no mortality overall [11]. This was the case in our 
patient that was treated conservatively with an endoluminal stent. Regarding late 
complications, we observed two patients (11.8%), one with a trocar-site ventral hernia 
and one with an incisional ventral hernia repair. The later was one of the three 
conversions (17.6%) which were required for re-SG. 
In short, re-SG may be a valid surgical option for patients with weight regain after BPD-
DS. Our series show that re-SG after BPD-DS is feasible, effective and safe. However, 
patients have to be carefully considered for revisional surgery since re-SG is associated 
with the potential risk for surgical complications. 
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Figure legends 
Figure 1:  
Comparison of weight (kg) at time of BPD-DS, before re-SG, and during follow-up at 1 
and 3 years 
 
Figure 2:  
Comparison of BMI (kg/m2) at time of BPD-DS, before re-SG, and during follow-up at 1 
and 3 years 
 
Figure 3:  
Comparison of %EWL at time of re-SG, and during follow-up at 1 and 3 years 
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